One mechanism for this immune suppression is that the expression of CD200 on tumor cells enhances the release of IL-10 by tumor-associated myeloid cells, contributes to immune suppression and favors tumor progression and recurrence [19]. This evidence concerns the gene IL10 and neoplasm.